Mexico will become the 39th member of the Council of Europe’s drug policy cooperation platform The Pompidou Group, it was announced today by the Council of Europe’s Committee of Ministers.
Earlier this month in Venice, Ambassador Santiago Oñate Laborde of Mexico presented Mexico’s drug policies and future perspectives for cooperation to the Pompidou Group member states at a meeting.
Key reasons for Mexico’s decision to join include the following: Pompidou Group efforts to support balanced and innovative drug policies, executive training programmes, and the Group’s contributions to the UN General Assembly Special Session on Drugs (UNGASS) in 2016. The Pompidou Group provides an international forum for policy-makers, professionals and researchers to discuss and exchange information on the whole range of drug misuse and trafficking problems. In order to carry out this mission, it adopts a multidisciplinary, integrated approach to all drug problems and employs a variety of working methods.
Mexico will formally join the group as of 1 January 2017.
See also:
Mexico and the Council of Europe
